HUYA (NYSE:HUYA) Azioni

HUYA

Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.

Charging,Bull,Is,A,Bronze,Sculpture,That,Stands,On,Broadway,

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

QNST

L&#39;analisi tecnica basata sull&#39;RSI evidenzia tre titoli del settore tecnologico e delle telecomunicazioni che mostrano segnali di ipercomprato.

Crollo in vista nel settore tech? Gli indicatori segnalano queste 3 azioni

HUYA Inc. American depositary shares, each representing one Class A ordinary share

HUYA Inc

Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) sees FY2026 sales of $3.515 billion vs $3.51 billion analyst estimate.

Guidance

PSTG

Pure Storage Sees FY2026 Sales $3.515B vs $3.51B Est

JPMorgan analyst Pinjalim Bora maintained a Neutral rating on GitLab Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) and set a <a href="https://in.benzinga.com/quote/GTLB/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $58</a> on Wednesday.
Bora is tactically positive going into the first quarter, largely because the stock has lagged the broader market while GitLab&#8217;s demand trends are likely stable.
The analyst expects a normal beat cadence, similar to the last few quarters, driving high 20% growth, partially aided by pricing benefits.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45551481/palo-altos-ai-momentum-make-it-a-top-cybersecurity-pick-analyst-says" target="_blank" rel="noreferrer noopener">Palo Alto&#8217;s AI Momentum Make It A Top Cybersecurity Pick, Analyst Says</a>
Additionally, he expects the company to maintain a conservative guidance posture and likely guide the second quarter much closer to the pin while flowing in the first-quarter beat into the full year.
Finally, Bora noted there is likely to be a decent amount of cushion on the profitability side, as he estimated headcount growth exiting the first quarter, running slightly below consensus operating expenditure growth assumptions for fiscal 2026.
At the same time, the analyst is slightly cautious of the refinements around sales and GTM that the new CRO might put in place, both across new customer acquisition and expansion plays. Bora is also unsure how to interpret the pricing and packaging changes.
While Bora appreciated GitLab&#8217;s continuous innovation and strategic role in the software development value chain, he maintained his Neutral rating due to the challenges posed by Agentic AI&#8217;s impact on developer headcount and evolving competition in the DevSecOps space.
In May, Bora noted some pricing and packaging changes, including promotions around the Premium SKU and packaging changes around AI capabilities.
GitLab has updated its pricing promotions around the Premium SKU. The analyst noted that these promotions have been in effect at least since the second half of calendar 2024 and were largely focused on smaller companies as GitLab tests the price sensitivity of its low-end customer base.
Concerning pricing on its AI-related SKUs, Bora noted that with the launch of GitLab 18, the company seems to be folding the AI-code suggestion capabilities, along with Duo Chat into the existing pricing constructs of Premium and Ultimate SKUs, for both Cloud and Self-managed customers, essentially offering them for free. 
The analyst noted that this compares to these AI features previously being part of the paid add-ons. Additionally, the company is relaxing the purchase requirements around Duo enterprise, allowing even Premium SKU customers to buy that AI SKU versus previously, which was limited to only Ultimate SKU customers, he said.
Analyzing website traffic to GitLab.com as a signal for top-of-the-funnel trends for GitLab, Bora noted a deceleration in both total visitor growth and unique visitor growth for the three months ending April (or fiscal first quarter), as compared to the previous quarter. More specifically, total visitors declined -17% Y/Y in the fiscal first quarter (versus -16% last quarter), while unique visitors declined -24% in the fiscal first quarter (versus -15% last quarter).
Based on data from LinkedIn, Bora noted that GitLab&#8217;s Y/Y total headcount growth remained relatively stable in April (at +17% Y/Y versus ~17% in January or fiscal fourth quarter), while sales headcount growth marked a slight uptick in April (+2% versus -1% in January or fiscal fourth quarter).
GitLab projected first-quarter revenue of $213 million and adjusted EPS of 14 cents..
GTLB Price Action: GitLab stock is down 3.65% at $46.25 at market close on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/media/25/05/45634446/microsoft-pulls-ahead-in-ai-race-with-key-partnerships-across-openai-nvidia-and-elon-musks-xai" target="_blank" rel="noreferrer noopener">Microsoft Pulls Ahead In AI Race With Key Partnerships Across OpenAI, Nvidia, And Elon Musk&#8217;s xAI</a></li>
</ul>
Photo: Lori Butcher via Shutterstock

Price Target

Reiteration

Analyst Ratings

Tech

GTLB

GitLab's AI Pricing Changes, CRO Strategy Make JPMorgan Analyst Cautious Despite Expected Q1 Beat

Earnings

Earnings Beats

e.l.f. Beauty Q4 Adj. EPS $0.78 Beats $0.72 Estimate, Sales $332.64M Beat $327.47M Estimate

NTNX

Nutanix Expects Q4 Revenue Of $635M - $645M; Sees FY25 Revenue Of $2.52B - $2.53B

Earnings Misses

VEEV

Veeva Sys Q1 Adj. EPS $1.37 Misses $1.74 Estimate, Sales $759.00M Beat $731.91M Estimate

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) affirms FY2025 Adj EPS guidance from $5.54-$5.61 to $5.54-$5.61 vs $5.55 analyst estimate. Raises FY2025 sales outlook from $6.68 billion-$6.76 billion to $6.73 billion-$6.81 billion vs $6.73 billion estimate.

Agilent Technologies Affirms FY2025 Adj EPS Guidance of $5.54-$5.61 vs $5.55 Est; Raises FY2025 Sales Guidance from $6.68B-$6.76B to $6.73B-$6.81B vs $6.73B Est

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) is looking for Q3 Adj EPS of $1.35-$1.37 vs $1.39 analyst estimate. sees sales of $1.645 billion-$1.675 billion vs $1.65 billion analyst estimate.

Agilent Technologies Sees Q3 Adj EPS $1.35-$1.37 vs $1.39 Est; Sees Sales $1.645B-$1.675B vs $1.65B Est

Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.25 by 16 percent. This is a 9.38 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $778.50 million which beat the analyst consensus estimate of $770.23 million by 1.07 percent. This is a 12.26 percent increase over sales of $693.48 million the same period last year.

Pure Storage Q1 Adj. EPS $0.29 Beats $0.25 Estimate, Sales $778.50M Beat $770.23M Estimate

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) reported quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.38 by 8.58 percent. This is a 22.33 percent increase over earnings of $3.00 per share from the same period last year. The company reported quarterly sales of $1.60 billion which met the analyst consensus estimate. This is a 10.24 percent increase over sales of $1.46 billion the same period last year.

SNPS

Synopsys Q2 Adj. EPS $3.67 Beats $3.38 Estimate, Sales $1.60B Inline

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.26 by 3.97 percent. This is a 7.38 percent increase over earnings of $1.22 per share from the same period last year. The company reported quarterly sales of $1.67 billion which beat the analyst consensus estimate of $1.63 billion by 2.54 percent. This is a 6.04 percent increase over sales of $1.57 billion the same period last year.

Agilent Technologies Q2 Adj. EPS $1.31 Beats $1.26 Estimate, Sales $1.67B Beat $1.63B Estimate

Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.38 by 10.53 percent. This is a 75 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $638.98 million which beat the analyst consensus estimate of $626.00 million by 2.07 percent. This is a 21.81 percent increase over sales of $524.58 million the same period last year.

Nutanix Q3 Adj. EPS $0.42 Beats $0.38 Estimate, Sales $638.98M Beat $626.00M Estimate

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4437419-1&amp;h=4199890651&amp;u=http%3A%2F%2Fwww.imux.com%2F&amp;a=Immunic%2C+Inc.">Immunic, Inc.</a> ("Immunic" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMUX#NASDAQ">IMUX</a>), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that it has commenced an underwritten public offering of (i) pre-funded warrants to purchase shares of common stock, (ii) Series A warrants to purchase shares of common stock (or pre-funded warrants) expiring on December 31, 2025, (iii) and Series B warrants to purchase shares of common stock (or pre-funded warrants) expiring five years following the issuance date. The Series A and B warrants will&nbsp;immediately&nbsp;expire in&nbsp;proportion&nbsp;to&nbsp;the&nbsp;extent that&nbsp;the corresponding&nbsp;pre-funded&nbsp;warrant&nbsp;offered&nbsp;hereby is&nbsp;exercised&nbsp;on&nbsp;or&nbsp;prior to&nbsp;September&nbsp;30,&nbsp;2025, subject to certain exceptions. All of the securities to be sold in the proposed offering will be offered by Immunic. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
The Company intends to use the net proceeds received from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
Leerink Partners is acting as the sole bookrunner for the offering.&nbsp;

Offerings

IMUX

Immunic Announces Proposed Public Offering; No Size Or Amount Disclosed

Investors with a lot of money to spend have taken a bullish stance on MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MELI, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 12 uncommon options trades for MercadoLibre.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 16%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $186,670, and 9 are calls, for a total amount of $532,168.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1000.0 to $2700.0 for MercadoLibre over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for MercadoLibre's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across MercadoLibre's significant trades, within a strike price range of $1000.0 to $2700.0, over the past month.
<h3>MercadoLibre Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748462653_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1623.6</td>
<td>$1608.0</td>
<td>$1612.71</td>
<td>$1000.00</td>
<td>$161.2K</td>
<td align="right">20</td>
<td align="right">1</td>
</tr>
<tr>
<td>MELI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$38.6</td>
<td>$34.1</td>
<td>$34.1</td>
<td>$2300.00</td>
<td>$112.5K</td>
<td align="right">69</td>
<td align="right">34</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$792.0</td>
<td>$778.0</td>
<td>$792.0</td>
<td>$2500.00</td>
<td>$79.2K</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$184.6</td>
<td>$174.9</td>
<td>$184.6</td>
<td>$2600.00</td>
<td>$73.8K</td>
<td align="right">17</td>
<td align="right">4</td>
</tr>
<tr>
<td>MELI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$107.1</td>
<td>$91.5</td>
<td>$98.3</td>
<td>$2545.00</td>
<td>$49.1K</td>
<td align="right">0</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About MercadoLibre</h3>
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
<h3>Where Is MercadoLibre Standing Right Now?</h3>
<ul>
<li>With a volume of 218,305, the price of MELI is down -0.27% at $2548.25. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 64 days.</li>
</ul>
<h3>What Analysts Are Saying About MercadoLibre</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $2900.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Overweight rating on MercadoLibre, maintaining a target price of $3100. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on MercadoLibre, which currently sits at a price target of $3000. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Neutral rating on MercadoLibre with a target price of $2600. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MercadoLibre with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

MELI

Looking At MercadoLibre's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Delta Air Lines.
Looking at options history for Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $302,453 and 4, calls, for a total amount of $236,144.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $44.0 to $60.0 for Delta Air Lines over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Delta Air Lines stands at 3695.75, with a total volume reaching 2,239.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Delta Air Lines, situated within the strike price corridor from $44.0 to $60.0, throughout the last 30 days.
<h3>Delta Air Lines Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748462648_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.55</td>
<td>$1.52</td>
<td>$1.52</td>
<td>$50.00</td>
<td>$107.6K</td>
<td>11.4K</td>
<td align="right">788</td>
</tr>
<tr>
<td>DAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$6.5</td>
<td>$6.4</td>
<td>$6.45</td>
<td>$49.00</td>
<td>$92.2K</td>
<td>6</td>
<td align="right">143</td>
</tr>
<tr>
<td>DAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$3.95</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$44.00</td>
<td>$86.6K</td>
<td>77</td>
<td align="right">222</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.46</td>
<td>$1.44</td>
<td>$1.44</td>
<td>$60.00</td>
<td>$57.9K</td>
<td>7.4K</td>
<td align="right">410</td>
</tr>
<tr>
<td>DAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$50.00</td>
<td>$56.6K</td>
<td>3.2K</td>
<td align="right">149</td>
</tr>
</tbody>
</table>

<h3>About Delta Air Lines</h3>
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
In light of the recent options history for Delta Air Lines, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Delta Air Lines's Current Market Status</h3>
<ul>
<li>Trading volume stands at 5,483,504, with DAL's price down by -1.31%, positioned at $48.76.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 43 days.</li>
</ul>
<h3>What The Experts Say On Delta Air Lines</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $56.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on Delta Air Lines, which currently sits at a price target of $46. 
&#x2A; In a positive move, an analyst from UBS has upgraded their rating to Buy and adjusted the price target to $66. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Delta Air Lines options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Behind the Scenes of Delta Air Lines's Latest Options Trends

Benzinga's options scanner has just identified more than 8 option transactions on Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>), with a cumulative value of $615,623. Concurrently, our algorithms picked up 4 puts, worth a total of 398,883.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $310.0 to $360.0 for Eaton Corp over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Eaton Corp's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eaton Corp's significant trades, within a strike price range of $310.0 to $360.0, over the past month.
<h3>Eaton Corp Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748462642_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$49.0</td>
<td>$44.5</td>
<td>$45.9</td>
<td>$340.00</td>
<td>$137.7K</td>
<td>0</td>
<td align="right">30</td>
</tr>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$44.1</td>
<td>$42.0</td>
<td>$42.6</td>
<td>$340.00</td>
<td>$127.8K</td>
<td>2</td>
<td align="right">30</td>
</tr>
<tr>
<td>ETN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$3.9</td>
<td>$2.95</td>
<td>$3.79</td>
<td>$360.00</td>
<td>$113.7K</td>
<td>1.0K</td>
<td align="right">300</td>
</tr>
<tr>
<td>ETN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$31.1</td>
<td>$30.6</td>
<td>$30.6</td>
<td>$330.00</td>
<td>$91.8K</td>
<td>283</td>
<td align="right">30</td>
</tr>
<tr>
<td>ETN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$14.1</td>
<td>$13.6</td>
<td>$14.0</td>
<td>$330.00</td>
<td>$72.8K</td>
<td>824</td>
<td align="right">53</td>
</tr>
</tbody>
</table>

<h3>About Eaton Corp</h3>
Founded in 1911 by Joseph Eaton, the eponymous company began by selling truck axles in New Jersey. Eaton has since become an industrial powerhouse largely through acquisitions in various end markets. Eaton's portfolio can broadly be divided into two parts: its electrical and industrial businesses. Its electrical portfolio (representing around 70% of company revenue) sells components within data centers, utilities, and commercial and residential buildings, while its industrial business (30% of revenue) sells components within commercial and passenger vehicles and aircraft. Eaton receives favorable tax treatment as a domiciliary of Ireland, but it generates over half of its revenue within the US.
Following our analysis of the options activities associated with Eaton Corp, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Eaton Corp</h3>
<ul>
<li>With a trading volume of 1,168,056, the price of ETN is down by -0.81%, reaching $325.49.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 64 days from now.</li>
</ul>
<h3>Expert Opinions on Eaton Corp</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $333.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Eaton Corp, maintaining a target price of $300. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Eaton Corp, targeting a price of $310. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Eaton Corp with a target price of $351. 
&#x2A; An analyst from Evercore ISI Group persists with their In-Line rating on Eaton Corp, maintaining a target price of $349. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Eaton Corp, which currently sits at a price target of $355. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eaton Corp, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Decoding Eaton Corp's Options Activity: What's the Big Picture?

Taysha Gene Therapies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. All of the securities will be offered by Taysha. Taysha also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering under the same terms and conditions (including shares underlying the pre-funded warrants). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
Jefferies, BofA Securities, Piper Sandler and Barclays are acting as joint book-running managers for the proposed offering.
A shelf registration statement relating to the securities offered in the public offering described above was filed with the Securities and Exchange Commission (the SEC) on December 13, 2024, and declared effective by the SEC on December 20, 2024. The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at <a href="http://www.sec.gov/">www.sec.gov</a>. Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may also be obtained by contacting Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) 821-7388, or by e-mail at Prospectus_Department@Jefferies.com; BofA Securities Inc., Attention: Prospectus Department, 201 North Tryon Street, NC1-022-02-25 Charlotte, NC 28255- 0001, or by e-mail at dg.prospectus_requests@bofa.com; Piper Sandler &amp; Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, or by telephone at (800) 747-3924, or by e-mail at prospectus@psc.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at (888) 603-5847, or by email at <a href="mailto:Barclaysprospectus@broadridge.com">Barclaysprospectus@broadridge.com</a>.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Company's management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process and a clinically and commercially proven AAV9 capsid in an effort to rapidly translate treatments from bench to bedside.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipates," "believes," "expects," "intends," "projects," "plans," and "future" or similar expressions are intended to identify forward-looking statements. Forward-looking statements include statements concerning the potential of TSHA-102 and Taysha's other product candidates to positively impact quality of life and alter the course of disease in the patients Taysha seeks to treat, Taysha's research, development and regulatory plans for its product candidates and Taysha's anticipated public offering, including the uncertainties related to market conditions and the completion of the public offering on the anticipated terms, if at all. Forward-looking statements are based on management's current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied by such forward-looking statements. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding Taysha's business are described in detail in its SEC filings, including in Taysha's Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, which are available on the SEC's website at <a href="http://www.sec.gov/">www.sec.gov</a>. Additional information will be made available in other filings that Taysha makes from time to time with the SEC. These forward-looking statements speak only as of the date hereof, and Taysha disclaims any obligation to update these statements except as may be required by law.

Biotech

General

TSHA

Taysha Gene Therapies Announces Proposed Public Offering Of Common Stock; Terms Not Disclosed

Salesforce Q1 Adj. EPS $2.58 Beats $2.55 Estimate, Sales $9.83B Beat $9.75B Estimate

After years of being the poster child for China&#8217;s regulatory reckoning, Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) is now sending a different sort of signal to shareholders: It&#8217;s back, it&#8217;s profitable and it&#8217;s on the AI wave on a large scale. And for <a href="https://www.benzinga.com/etfs">ETF investors</a>, its return may be more than a BABA-centric tale, which might be a sign of a wider reawakening for China-centric tech ETFs.
The Numbers Don&#8217;t Lie, They Shout
Alibaba&#8217;s most <a href="https://www.benzinga.com/news/earnings/25/05/45437447/alibaba-stock-slides-5-after-revenue-miss-cloud-spend-hits-free-cash-flow">recent quarterly earnings</a> showed that the company&#8217;s revenue increased 7% year-over-year in the March quarter, which was a miss. However, operating income skyrocketed 93%, and adjusted EBITA jumped 36%. The jaw-dropping number? Net income expanded to $1.65 billion, an eye-opening 1,203% jump from the prior-year period. Even stripping out one-time gains, non-GAAP net income was up 22%. The company has also stepped up expenses, cut share-based compensation in half, and streamlined its sprawling platforms—all while accelerating cash flow by 18%. For a company once seen as a regulatory landmine, Alibaba is now flexing financial discipline and strategic clarity.
Also Read: <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45620670/alibaba-eyes-growth-in-other-markets-as-us-ties-strained-says-chairman">Alibaba Eyes Growth In Other Markets As US Ties Strained, Says Chairman</a> Alibaba&#8217;s Not-So-Secret Weapon
As e-commerce remains the company&#8217;s anchor business, Alibaba&#8217;s Cloud Intelligence Group is shaping up to be the next significant growth driver. The cloud unit increased revenue by 18% YoY to $4.15 billion, while adjusted EBITDA surged 69%. But the real news is what&#8217;s fueling that growth: artificial intelligence.
Alibaba has now reported seven straight quarters of triple-digit revenue growth from AI-driven cloud products. CEO Eddie Wu has referred to generative AI as the key driver here, a trend that international investors are following closely, particularly as AI emerges as the next wave across enterprise and consumer applications. The ETF Implication: Who&#8217;s Holding The Bag (In A Good Way)?
For&nbsp;investors&nbsp;in&nbsp;ETFs who want&nbsp;to&nbsp;play&nbsp;Alibaba&#8217;s&nbsp;rebound&nbsp;without&nbsp;committing&nbsp;all&nbsp;to&nbsp;a&nbsp;single&nbsp;stock,&nbsp;there&nbsp;are many&nbsp;funds&nbsp;with&nbsp;significant&nbsp;exposure: KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>)
With 12% weighting in Alibaba, KWEB has been a favorite among those wagering on the Chinese internet rebound. The ETF also provides some exposure to Tencent (OTCPK: TCEHY), JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), and Meituan, providing diversified access to the group. Invesco Golden Dragon China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGJ#NASDAQ">PGJ</a>)
This fund invests in U.S.-listed Chinese shares, such as Alibaba (8% weightage), and goes heavy on tech-heavy names. It provides a pure play for those interested in the innovation economy of China without having to contend with A-shares. iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>)
A more diversified China play and a significant position in Alibaba (~10%), MCHI may attract investors who want to mix tech with some exposure to financials, real estate, and industrials. Not All Dragons Breathe Fire
While Alibaba&#8217;s Q4&nbsp;results&nbsp;are&nbsp;certainly&nbsp;to be applauded, it&#8217;s not&nbsp;a&nbsp;decade&nbsp;of&nbsp;peace&nbsp;and&nbsp;prosperity&nbsp;on the China tech horizon. The&nbsp;larger&nbsp;China tech&nbsp;story&nbsp;is&nbsp;still&nbsp;susceptible&nbsp;to geopolitical&nbsp;stress,&nbsp;local&nbsp;regulator&nbsp;switches, and sentiment investor turns. ETFs can insulate single-stock risk but aren&#8217;t proof against macro headwinds.
Nevertheless, the green shoots are difficult to overlook. Following years of investor doubts, Alibaba&#8217;s robust quarter may be the catalyst China tech ETFs have been waiting for.
For ETF investors, particularly those who hold long positions in KWEB, PGJ, and MCHI, the last earnings call hinted that the tide could be turning for China tech. With AI traction, cloud profitability, and a solid core commerce engine, Alibaba no longer looks like a cautionary tale. The Alibaba stock is up 38% year-to-date.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45655155/exxon-stock-vs-chevron-the-11-billion-barrel-oil-war-that-could-shake-up-energy-etfs">Exxon Stock Vs. Chevron: The 11 Billion Barrel Oil War That Could Shake Up Energy ETFs</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

ETFs

BABA

KWEB

MCHI

PowerShares Golden Dragon Halter USX China Portfolio

TCEHY

China Tech's Revival Starts With Alibaba: ETFs To Watch As The Dragon Wakes

During the last three months, 4 analysts shared their evaluations of E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $2.6, along with a high estimate of $3.30 and a low estimate of $2.30. A negative shift in sentiment is evident as analysts have decreased the average price target by 2.62%. 
<img src="https://www.benzinga.com/files/images/story/2025/1748462480_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of E2open Parent Holdings by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$3.30</td>
<td>$2.10</td>
</tr>
<tr>
<td>Taylor McGinnis</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$2.30</td>
<td>$3.00</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$2.30</td>
<td>$2.60</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to E2open Parent Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of E2open Parent Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of E2open Parent Holdings's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ETWO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on E2open Parent Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know E2open Parent Holdings Better</h2>
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority revenue is from the Americas.
<h3>E2open Parent Holdings's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Decline in Revenue: Over the 3M period, E2open Parent Holdings faced challenges, resulting in a decline of approximately -3.64% in revenue growth as of 28 February, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: E2open Parent Holdings's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -159.94%, the company may face hurdles in effective cost management.
Return on Equity (ROE): E2open Parent Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -25.24%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): E2open Parent Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -9.78%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: E2open Parent Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.26, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ETWO

4 Analysts Assess E2open Parent Holdings: What You Need To Know

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $88.73, along with a high estimate of $105.00 and a low estimate of $65.00. Highlighting a 5.52% decrease, the current average has fallen from the previous average price target of $93.91. 
<img src="https://www.benzinga.com/files/images/story/2025/1748462465_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive CarMax is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$84.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$65.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$107.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CarMax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CarMax compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of CarMax's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of CarMax's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KMX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CarMax analyst ratings.</a>
<h2>About CarMax</h2>
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
<h3>Financial Insights: CarMax</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3M period, CarMax showcased positive performance, achieving a revenue growth rate of 6.69% as of 28 February, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: CarMax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.5%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): CarMax's ROE stands out, surpassing industry averages. With an impressive ROE of 1.44%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.33%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 3.08, CarMax adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

11 Analysts Have This To Say About CarMax

Entertainment

Press Releases

HUYA Inc. to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

HUYA Inc. Reports Third Quarter 2024 Unaudited Financial Results

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

HUYA Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 18, 2025

HUYA Inc. Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and Announces Dividend Plan

Dividends

HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

HUYA Inc. Provides Update on Share Repurchase Program

HUYA Inc. Files 2024 Annual Report on Form 20-F

HUYA Inc. to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

HUYA Inc. Reports First Quarter 2025 Unaudited Financial Results

DoubleDown Interactive Co., Ltd. - American Depository Shares

DoubleDown Interactive Co

DouYu International Holdings Limited - American Depositary Shares

DouYu Intl Hldgs

Electronic Arts

GCL Global Holdings Ltd - Ordinary Shares

GCL Global Holdings

GDEV

Golden Matrix Group

Gamehaus Holdings Inc. - Class A Ordinary Shares

Gamehaus Holdings

GRAVITY Co., Ltd. - American depositary shares, each representing one common share.

GRAVITY Co

Gaxos.AI

iHuman Inc. American depositary shares, each representing five Class A ordinary shares

iHuman

Motorsport Games Inc. - Class A Common Stock

Motorsport Games

PLAYSTUDIOS

NetEase, Inc. - American Depositary Shares, each representing 5 ordinary shares

NetEase

Playtika Holding

Roblox

Sea Limited American Depositary Shares, each representing one Class A Ordinary Share

Comments

HUYA

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO